Hugo Kohnke

1.3k total citations · 1 hit paper
10 papers, 848 citations indexed

About

Hugo Kohnke is a scholar working on Genetics, Oncology and Rheumatology. According to data from OpenAlex, Hugo Kohnke has authored 10 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Oncology and 3 papers in Rheumatology. Recurrent topics in Hugo Kohnke's work include Chronic Lymphocytic Leukemia Research (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Hugo Kohnke is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Hugo Kohnke collaborates with scholars based in Sweden, United Kingdom and Netherlands. Hugo Kohnke's co-authors include Mia Wadelius, Niclas Eriksson, Anke H. Maitland‐van der Zee, Ann K. Daly, Julian Leathart, Patrick Kesteven, Peter Avery, Girvan Burnside, Andrea Jorgensen and Toby Nicholson and has published in prestigious journals such as New England Journal of Medicine, Clinical Pharmacology & Therapeutics and Clinica Chimica Acta.

In The Last Decade

Hugo Kohnke

10 papers receiving 831 citations

Hit Papers

A Randomized Trial of Genotype-Guided Dosing of Warfarin 2013 2026 2017 2021 2013 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugo Kohnke Sweden 8 479 214 172 145 113 10 848
HL McLeod United States 8 563 1.2× 137 0.6× 153 0.9× 149 1.0× 155 1.4× 15 927
C. Michael Stein United States 7 574 1.2× 166 0.8× 175 1.0× 133 0.9× 267 2.4× 9 1.1k
Nita A. Limdi United States 17 781 1.6× 230 1.1× 124 0.7× 121 0.8× 75 0.7× 24 1.1k
JL Anderson United States 4 319 0.7× 226 1.1× 91 0.5× 113 0.8× 97 0.9× 6 693
Toby Nicholson United Kingdom 2 394 0.8× 198 0.9× 76 0.4× 49 0.3× 84 0.7× 4 606
Cheng Hock Toh United Kingdom 6 427 0.9× 223 1.0× 77 0.4× 47 0.3× 98 0.9× 7 727
Massimiliano Chetta Italy 13 487 1.0× 155 0.7× 211 1.2× 120 0.8× 49 0.4× 38 978
Leonard Grosso United States 8 759 1.6× 186 0.9× 146 0.8× 98 0.7× 92 0.8× 10 1.1k
Jasmine A. Luzum United States 17 247 0.5× 256 1.2× 176 1.0× 76 0.5× 108 1.0× 50 870
J. L. Anderson United States 2 372 0.8× 146 0.7× 82 0.5× 61 0.4× 88 0.8× 4 606

Countries citing papers authored by Hugo Kohnke

Since Specialization
Citations

This map shows the geographic impact of Hugo Kohnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Kohnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Kohnke more than expected).

Fields of papers citing papers by Hugo Kohnke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo Kohnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Kohnke. The network helps show where Hugo Kohnke may publish in the future.

Co-authorship network of co-authors of Hugo Kohnke

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Kohnke. A scholar is included among the top collaborators of Hugo Kohnke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Kohnke. Hugo Kohnke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Cavalli, Marco, Niclas Eriksson, Hugo Kohnke, et al.. (2022). Genome-Wide Association Study of Liver Enzyme Elevation in an Extended Cohort of Rheumatoid Arthritis Patients Starting Low-Dose Methotrexate. Pharmacogenomics. 23(15). 813–820. 5 indexed citations
2.
Kohnke, Hugo, et al.. (2021). [New recommendation on pharmacogenetic screening prior to 5-fluorouracil based cancer treatment - Swedish experience indicates less adverse effects and healthcare cost savings].. Läkartidningen. 118. 1 indexed citations
3.
Baecklund, Eva, Niclas Eriksson, Hugo Kohnke, et al.. (2021). Genome-Wide Association Study of Liver Enzyme Elevation in Rheumatoid Arthritis Patients Starting Methotrexate. Pharmacogenomics. 22(15). 973–982. 8 indexed citations
4.
Baecklund, Eva, et al.. (2020). MTHFR,TYMSandSLCO1B1Polymorphisms and Adverse Liver Effects of Methotrexate in Rheumatoid Arthritis. Pharmacogenomics. 21(5). 337–346. 8 indexed citations
5.
Hallberg, Pär, Hans Smedje, Niclas Eriksson, et al.. (2019). Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival. EBioMedicine. 40. 595–604. 36 indexed citations
6.
Wadelius, Mia, Niclas Eriksson, Reinhold Kreutz, et al.. (2017). Sulfasalazine‐Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. Clinical Pharmacology & Therapeutics. 103(5). 843–853. 14 indexed citations
7.
Pirmohamed, Munir, Girvan Burnside, Niclas Eriksson, et al.. (2013). A Randomized Trial of Genotype-Guided Dosing of Warfarin. New England Journal of Medicine. 369(24). 2294–2303. 590 indexed citations breakdown →
8.
Howard, Rebecca, Julian Leathart, David J. French, et al.. (2011). Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes. Clinica Chimica Acta. 412(23-24). 2063–2069. 26 indexed citations
9.
Glimelius, Bengt, Hans Garmo, Åke Berglund, et al.. (2010). Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer. The Pharmacogenomics Journal. 11(1). 61–71. 107 indexed citations
10.
Kohnke, Hugo, et al.. (2005). Warfarin dose related to apolipoprotein E (APOE) genotype. European Journal of Clinical Pharmacology. 61(5-6). 381–388. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026